Automated Cervical Screening Using Multi-Parameter Flow Cytometry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting cervical abnormalities, such as cervical cancer, are plagued by low sensitivity, high false-negative rates, and require highly trained staff and expensive laboratories, making them labor-intensive and inefficient.
Innovation Solution
The development of multi-parameter analysis methods and automated devices that use fluorescently labeled probing agents to measure fluorescent activities and light scattering parameters, allowing for the accurate classification of cervical cells as precancerous, cancerous, or normal by analyzing multiple parameters including biomarkers like p16INK4a and Mcm5.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional Pap smear methods are used, then the testing process is simple and requires minimal equipment, but the sensitivity is low and false-negative rates are high
Solution Approach 1:
The invention changes the detection parameters from simple visual morphological assessment to multi-parameter flow cytometric analysis including forward scatter, side scatter, and multiple fluorescent channels. This enables quantitative measurement of cellular properties and biomarker expression levels, significantly improving detection accuracy and sensitivity while reducing false-negative rates.
Solution Approach 2:
The invention introduces fluorescently labeled probing agents as intermediaries that specifically bind to biomarkers on cervical cells. These probes act as mediators between the detection system and the target cells, enabling specific identification of precancerous and cancerous cells through fluorescence signals detected by flow cytometry.
2Reliability
If automated multi-parameter analysis is implemented, then detection accuracy and sensitivity improve, but device complexity and cost increase
Solution Approach 1:
The automated flow cytometry system performs self-service by automatically acquiring multi-parameter data, gating cell populations, calculating ratios, and generating diagnostic reports without manual intervention. This automation reduces reliance on highly trained staff while maintaining high detection accuracy, making the system more accessible to facilities with limited expertise.
3Productivity
If subjective visual readings are used, then the testing process is quick and simple, but labor intensity is high and efficiency is low
Solution Approach 1:
The invention replaces the mechanical/visual inspection process with an automated flow cytometry system that uses optical detection and computational analysis. This substitution eliminates subjective visual readings and manual slide examination, enabling high-throughput automated screening that improves productivity while maintaining operational simplicity through computerized control and automated data interpretation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These methods and devices provide a more accurate, automated, and cost-effective means of screening for cervical abnormalities, reducing the reliance on subjective visual readings and improving the detection of precancerous and cancerous cells, thereby enhancing early detection and prevention of cervical cancer.
Implementation Method 1
measuring multiple parameters comprising at least two fluorescent activities and at least two types of light scattering for cells in the sample, wherein at least one of the fluorescent activities is produced by a fluorescently labeled probing agent that specifically recognizes a biomarker
Implementation Method 2
measuring multiple parameters comprising at least two fluorescent activities and at least two types of light scattering for cells in the sample
Data Source
AI summary
The present invention provides multi-parameter analysis methods for determining the presence or absence of pre-cancerous or cancerous cells in a cervical sample and for screening cervical abnormality in a cervical sample. The invention also provides an apparatus and automated methods for screening cervical abnormality in a sample. The invention further provides a sampling device and a sample collection assembly for collecting cell samples, including cervical samples.